医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

SEOUL, South Korea

The personalized medicine and biotechnology company, Macrogen (headed by Hyonyong Chong; www.macrogen.com) (KOSDAQ:038290), has announced a new Corporate Identity (CI) for a great leap forward to become a global leader of personalized genomic medicine.

Macrogen was founded in 1997 based on the management philosophy of “we help improve the quality of life for mankind by enhancing the understanding and availability of human genome information.” This year marks the company’s 19^th anniversary. During this time, the company has grown to be a global leader in personalized genomic medicine. Started as one of the first generation bio venture companies in Korea, Macrogen is now a global company in the genome analysis service sector. The new CI contains a powerful intention to achieve the vision of “to become the leader of Asian biotech industry with disease prediction technology and new medicine development capabilities based on gene information integrated content.”

Prior to renewing its CI, Macrogen has strengthened the company’s sustained growth foundation through profit-centered management with an objective dubbed “a global leader in personalized genomic medicine.” To achieve this objective, the company plans to create high added value through sustained growth genome analysis services, the core business, and clinical diagnostic sequencing and molecular diagnostic services. Also, the company will pursue advancement to the healthcare information-contents business at full scale using genome information-based big data by continuously implementing an Asian genome project and by building global genome networks. Based on such a plan, Macrogen aims to expand its gene and genome analysis business not only to the existing researchers-oriented market, but also to consumers market.

While inheriting the previous design that materialized the unified DNA double helix structure and a human figure, the symbol of the new Macrogen CI is expressed in a more dynamic and future-oriented way. At the same time, the blue, green, red and black colors of the previous CI, which symbolized the four base sequences constituting a DNA, were reinterpreted from a modern view point and expressed with a symbol with the double motif of a gene and a human in a natural and sophisticated way. For the company’s name, the capital letters that were used to highlight professionalism and reliability were changed to lowercase letters to stress the image of a more customer-oriented and consumer-friendly company. Furthermore, the previous image of a professional company that can be trusted was inherited through the development of a new color called “Macrogen Blue,” and by using bold letters that represent trust.

Along with this renewed CI, Macrogen introduced a new slogan, “Humanizing Genomics.” This slogan was developed with the brand concept of “a company that understands people and leads the future for a better life.” It contains the meaning of using genomics effectively by allowing it to easily gain access to our daily life, and the humanistic management philosophy of “realizing human-oriented genomics” and “contributing to human happiness through gene information.”

“Through the new CI, we will grow the brand image of Macrogen into a brand which symbolizes consumers’ faith that a healthier life can be enjoyed based on genome information during our daily life,” said Jeongsun Seo, the founder and the chairman of Macrogen. He added, “We will accelerate the realization of the era of customized medicine for individuals by making a new takeoff as a global leader in personalized genomic medicine.”

The renewal of Macrogen’s CI was realized through a brand contents development support project that was launched in August 2014 as part of “2014 Next Global Champ” sponsored by the Ministry of Trade, Industry and Energy.

NOTE TO EDITORS: Macrogen’s new CI can be found at http://www.macrogen.com/eng/company/philosophy.html and download the file from http://www.macrogen.com/eng/images/company/data/macrogen_ci.zip